Trust at Stake: Alzheimer’s Association’s role in FDA’s approval of Aduhelm

* A reflection on STAT article: Joseph, A. (June 16, 2021). Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm – and why critics should stop dwelling on the decision. Link: https://www.statnews.com/2021/06/16/qa-ceo-alzheimers-association-on-aduhelm/  A lot has been said and written in recent weeks about the FDA controversial approval of the drug Aduhelm and the […]